Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activities
Growth Metrics
Income Statement
Others
Ratios

Acro Biomedical (ACBM) Net Income (2016 - 2025)

Acro Biomedical (ACBM) has 10 years of Net Income data on record, last reported at $42526.0 in Q4 2025.

  • For Q4 2025, Net Income rose 498.44% year-over-year to $42526.0; the TTM value through Dec 2025 reached -$101146.0, down 139.13%, while the annual FY2025 figure was -$101146.0, 139.13% down from the prior year.
  • Net Income reached $42526.0 in Q4 2025 per ACBM's latest filing, up from -$117809.0 in the prior quarter.
  • Across five years, Net Income topped out at $2.2 million in Q4 2021 and bottomed at -$4.0 million in Q3 2022.
  • Average Net Income over 5 years is -$1.3 million, with a median of -$88651.5 recorded in 2021.
  • Peak YoY movement for Net Income: surged 3700.75% in 2021, then plummeted 6503.69% in 2022.
  • A 5-year view of Net Income shows it stood at $2.2 million in 2021, then plummeted by 276.9% to -$3.9 million in 2022, then surged by 99.54% to -$18240.0 in 2023, then skyrocketed by 41.49% to -$10673.0 in 2024, then skyrocketed by 498.44% to $42526.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Net Income were $42526.0 in Q4 2025, -$117809.0 in Q3 2025, and -$15562.0 in Q2 2025.